To provide recommendations for the appropriate use of scoring systems in prostate MRI to enhance consistency and communication in clinical practice, ultimately improving patient outcomes.
Key Findings:
PI-RADS v2.1 is essential for standardizing MRI acquisition and interpretation.
Prostate MRI reduces unnecessary biopsies and enhances detection of clinically significant prostate cancer.
Different scoring systems serve specific purposes in prostate cancer management, including active surveillance and recurrence risk assessment.
Interpretation:
Utilizing the correct scoring system in prostate MRI is crucial for accurate diagnosis, effective treatment planning, and improved communication among healthcare providers.
Limitations:
Confusion persists regarding the application of scoring systems in various clinical contexts; further education and training are recommended.
The role of dynamic contrast-enhanced imaging is debated, and non-contrast protocols may not be suitable for all patients; further research is needed.
Conclusion:
Adhering to standardized scoring systems like PI-RADS v2.1 is vital for optimizing prostate cancer diagnosis and management, and ongoing education for clinicians is essential.
by Andrea Ponsiglione, Giorgio Brembilla, Renato Cuocolo, Patricia Gutierrez, Ana Sofia Moreira, Martina Pecoraro, Jeries Zawaideh, Jelle Barentsz, Francesco Giganti, Anwar R. Padhani, Valeria Panebianco, Philippe Puech, Geert Villeirs
